Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-Versus-Host Disease
Open Access
- 12 May 2011
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 11 (6), 1148-1157
- https://doi.org/10.1111/j.1600-6143.2011.03558.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humansNature Reviews Immunology, 2007
- Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory MoleculesMolecular Therapy, 2007
- Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3Nature Immunology, 2007
- FKBP12 functions as an adaptor of the Smad7–Smurf1 complex on activin type I receptorJournal of Molecular Endocrinology, 2006
- Ex Vivo Rapamycin Generates Donor Th2 Cells That Potently Inhibit Graft-versus-Host Disease and Graft-versus-Tumor Effects via an IL-4-Dependent MechanismThe Journal of Immunology, 2005
- The Pim kinases control rapamycin-resistant T cell survival and activationThe Journal of Experimental Medicine, 2005
- Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow TransplantationThe Journal of Experimental Medicine, 2002
- The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethalityBlood, 2002
- FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycleProceedings of the National Academy of Sciences of the United States of America, 2001
- Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathwayNature, 1999